Pediatric IBD workshop calls for innovative trial design

Participants at an FDA-sponsored workshop called on regulators and drug developers to minimize placebo testing and other hurdles to clinical trial participation for pediatric inflammatory bowel disease, and maximize the use of innovative trial designs, efficacy extrapolation and real world evidence to accelerate approval of new IBD drugs for children. The meeting concluded with a

Read the full 555 word article

How to gain access

Continue reading with a
two-week free trial.